136 related articles for article (PubMed ID: 36543142)
1. Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.
Li H; Zhang J; Ke JR; Yu Z; Shi R; Gao SS; Li JF; Gao ZX; Ke CS; Han HX; Xu J; Leng Q; Wu GR; Li Y; Tao L; Zhang X; Sy MS; Li C
Cell Rep; 2022 Dec; 41(12):111834. PubMed ID: 36543142
[TBL] [Abstract][Full Text] [Related]
2. The E3 ubiquitin ligase Cbl-b inhibits tumor growth in multidrug-resistant gastric and breast cancer cells.
CHe X; Zhang Y; Qu X; Guo T; Ma Y; Li C; Fan Y; Hou K; Cai Y; Yu R; Zhou H; He X; Wu H; Liu Y; Xu L
Neoplasma; 2017; 64(6):887-892. PubMed ID: 28895413
[TBL] [Abstract][Full Text] [Related]
3. Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis.
Sehat B; Andersson S; Girnita L; Larsson O
Cancer Res; 2008 Jul; 68(14):5669-77. PubMed ID: 18632619
[TBL] [Abstract][Full Text] [Related]
4. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
[TBL] [Abstract][Full Text] [Related]
5. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
Paolino M; Choidas A; Wallner S; Pranjic B; Uribesalgo I; Loeser S; Jamieson AM; Langdon WY; Ikeda F; Fededa JP; Cronin SJ; Nitsch R; Schultz-Fademrecht C; Eickhoff J; Menninger S; Unger A; Torka R; Gruber T; Hinterleitner R; Baier G; Wolf D; Ullrich A; Klebl BM; Penninger JM
Nature; 2014 Mar; 507(7493):508-12. PubMed ID: 24553136
[TBL] [Abstract][Full Text] [Related]
6. CD2-associated protein (CD2AP) enhances casitas B lineage lymphoma-3/c (Cbl-3/c)-mediated Ret isoform-specific ubiquitination and degradation via its amino-terminal Src homology 3 domains.
Calco GN; Stephens OR; Donahue LM; Tsui CC; Pierchala BA
J Biol Chem; 2014 Mar; 289(11):7307-19. PubMed ID: 24425877
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells.
Li H; Xu L; Li C; Zhao L; Ma Y; Zheng H; Li Z; Zhang Y; Wang R; Liu Y; Qu X
Mol Cancer; 2014 Jun; 13():136. PubMed ID: 24885194
[TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.
Sévère N; Dieudonné FX; Marie PJ
Cell Death Dis; 2013 Jan; 4(1):e463. PubMed ID: 23328670
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin ligase Cbl-b and inhibitory Cblin peptides.
Nikawa T; Ishidoh K
Biochim Biophys Acta Proteins Proteom; 2020 Nov; 1868(11):140495. PubMed ID: 32663526
[TBL] [Abstract][Full Text] [Related]
10. {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase.
Girnita L; Shenoy SK; Sehat B; Vasilcanu R; Girnita A; Lefkowitz RJ; Larsson O
J Biol Chem; 2005 Jul; 280(26):24412-9. PubMed ID: 15878855
[TBL] [Abstract][Full Text] [Related]
11. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
[TBL] [Abstract][Full Text] [Related]
12. Binding of pro-prion to filamin A: by design or an unfortunate blunder.
Li C; Xin W; Sy MS
Oncogene; 2010 Sep; 29(39):5329-45. PubMed ID: 20697352
[TBL] [Abstract][Full Text] [Related]
13. The protein content of an adaptor protein, STAP-2 is controlled by E3 ubiquitin ligase Cbl.
Sekine Y; Yamamoto C; Ikeda O; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
Biochem Biophys Res Commun; 2009 Jun; 384(2):187-92. PubMed ID: 19401194
[TBL] [Abstract][Full Text] [Related]
14. Intersectin 1 enhances Cbl ubiquitylation of epidermal growth factor receptor through regulation of Sprouty2-Cbl interaction.
Okur MN; Ooi J; Fong CW; Martinez N; Garcia-Dominguez C; Rojas JM; Guy G; O'Bryan JP
Mol Cell Biol; 2012 Feb; 32(4):817-25. PubMed ID: 22158968
[TBL] [Abstract][Full Text] [Related]
15. c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus.
Nihal M; Wood GS
Oncotarget; 2016 Aug; 7(33):53869-53880. PubMed ID: 27472394
[TBL] [Abstract][Full Text] [Related]
16. E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells.
Xu L; Zhang Y; Qu X; Che X; Guo T; Cai Y; Li A; Li D; Li C; Wen T; Fan Y; Hou K; Ma Y; Hu X; Liu Y
Neoplasia; 2017 Apr; 19(4):374-382. PubMed ID: 28334634
[TBL] [Abstract][Full Text] [Related]
17. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
[TBL] [Abstract][Full Text] [Related]
18. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling.
Rorsman C; Tsioumpekou M; Heldin CH; Lennartsson J
J Biol Chem; 2016 May; 291(22):11608-18. PubMed ID: 27048651
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading.
Nakao R; Hirasaka K; Goto J; Ishidoh K; Yamada C; Ohno A; Okumura Y; Nonaka I; Yasutomo K; Baldwin KM; Kominami E; Higashibata A; Nagano K; Tanaka K; Yasui N; Mills EM; Takeda S; Nikawa T
Mol Cell Biol; 2009 Sep; 29(17):4798-811. PubMed ID: 19546233
[TBL] [Abstract][Full Text] [Related]
20. Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia.
Tang J; Tu S; Lin G; Guo H; Yan C; Liu Q; Huang L; Tang N; Xiao Y; Pope RM; Rajaram MVS; Amer AO; Ahmer BM; Gunn JS; Wozniak DJ; Tao L; Coppola V; Zhang L; Langdon WY; Torrelles JB; Lipkowitz S; Zhang J
J Exp Med; 2020 Apr; 217(4):. PubMed ID: 31999304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
